Alvogen and Dr Reddy’s US Suboxone Rivals Face Off Against Sandoz’ Authorized Generic

 
• By Dave Wallace

Alvogen and Dr Reddy’s have launched generic versions of Indivior’s Suboxone in the US, after the Supreme Court denied the originator’s attempt to further frustrate generic launches. But these two versions will compete with an authorized generic launched by Indivior through Sandoz.

StartingPistol
A US Supreme Court Decision Has Fired The Starting Pistol On Generic Competition To Suboxone

Alvogen and Dr Reddy’s have launched generic rivals to Indivior’s Suboxone (buprenorphine/naloxone) in the US, after the country’s Supreme Court denied a petition for a certiorari review of litigation over the sublingual film. At the same time, the originator has launched an authorized generic through partner Sandoz.

Marc Kikuchi, Dr Reddy’s recently-appointed chief executive officer of North America Generics (Also see "Dr Reddy's Brings In Kikuchi To Lead North America Generics" - Generics Bulletin, 12 February, 2019

More from Generics

More from Products